EASL Podcasts

The value of scientific collaboration and data sharing through registries and consortia is unequivocal. But what are the main challenges to building a consortium and how do we overcome them. Join the faculty as they provide you with a practical, experience-based view of how to build a successful consortium. Faculty Dr Marta Afonso (Moderator) Dr Mattias Mandorfer (Moderator) Prof. Jesús Bañales (F...

In the first episode of EASL Studio season 4, the faculty looked at the current status of hepatitis B elimination and discussed what needs to be done to achieve it. Faculty Dr Ahmed Elsharkawy (Moderator) Mr Danjuma K. Adda (Faculty) Prof. Maud Lemoine (Faculty) Prof. Jean-Michel Pawlotsky (Faculty) Dr John Ward (Faculty) Related episodes Special Edition : Live from Viral Hepatitis Elimination Con...

Results from current clinical trials are rapidly evolving, with mixed results. In this EASL Studio the faculty discuss: why certain trials have failed whereas others have succeeded, what we have learned about the connection between overall survival and progression-free survival as endpoints, and how the systemic therapy of HCC has evolved. Faculty Prof. Peter Galle (Moderator) Prof. Bruno Sangro (...

In this episode of EASL Studio the experts discuss a non-cirrhotic portal vein thrombosis (PVT): What is PVT in the absence of cirrhosis, The role of interventional radiology in the management of portal cavernoma, and An update from the VALDIG portal Vein Thrombosis meeting Faculty Prof. Pierre-Emmanuel Rautou (Moderator) Prof. Juan-Carlos Garcia-Pagan (Faculty) Dr Aurélie Plessier (Faculty) All E...

As we near the end of 2022, this EASL Studio reflects upon: Which topics were most published about Which fields will we focus on in 2023 What will the future of hepatology look like? Faculty Prof. Paolo Angeli (Moderator) Prof. Jessica Zucman-Rossi (Moderator) Prof. Thomas Berg (Faculty) Prof. Aleksander Krag (Faculty) All EASL Studio Podcasts are available on EASL Campus .

Traditionally, journal impact factor has been the way to measure the impact of ones scientific articles. However, social media platforms are increasingly being used for the dissemination of publications. Join the faculty as they debate novel metrics to measure the impact of articles. Faculty Prof. Jesus Banales (Moderator) Dr Atoosa Rabiee (Faculty) Dr Elliot Tapper (Faculty) Dr Juan Turnes (Facul...

Antimicrobial resistance (AMR) is growing problem that greatly impacts treatment outcome. In this episode the faculty discuss: The impact of prescribing antibiotics as primary and secondary prophylaxis on AMR rates What can be done globally to reduce AMR rates Faculty Prof. Debbie Shawcross (Moderator) Prof. Jonel Trebicka (Moderator) Prof. Jasmohan Bajaj (Faculty) Dr Lindsey Edwards (Faculty) Dr...

Currently, the only established therapeutic option for end-stage liver disease is orthotopic liver transplantation. However, the paucity of donor organs limits this option to only a few patients. From liver stem cells to advanced tissue bioengineering, this episode of EASL Studio discusses regenerative hepatology techniques as an alternative treatment for patients. Faculty Prof. Pedro Baptista (Mo...

In this JHEP Live the faculty discuss the use of antisense oligonucleotides and siRNAs in the treatment of chronic hepatitis B infections. Faculty Prof. Joerg Petersen (Moderator) Prof. Maria Buti (Faculty) Prof. Man-Fung Yuen (Faculty) All EASL Studio Podcasts are available on EASL Campus .

Listen to this EASL Studio to find out: Which policies for prioritisation exist within a deceased donor liver allocation system? What is the impact of novel cancer therapies on the selection of patients with prior cancer? Faculty Prof. Sherrie Bhoori (Moderator) Prof. Pål-Dag Line (Faculty) Prof. Vincenzo Mazzaferro (Faculty) Prof. Gonzalo Sapisochin (Faculty) All EASL Studio Podcasts are availabl...

In recent years, the role of the gut microbiome in the development and severity of various diseases has come to light. In this episode, the experts examines: The role of microbiome in obesity. The role of microbiome in the transition from NAFLD to NASH. Practical solutions in microbiome medications. Faculty Prof. Oren Shibolet (Moderator) Dr Aleksandra Kolodziejczyk (Faculty) Prof. Eran Elinav (Fa...

In honour of World Hospice and Palliative Care Day (8 October), this EASL Studio episode examines: When is the best time to think about end-of-life care in liver disease? What does it mean for the liver care team? When and how should patients be referred to specialised palliative care? Faculty Dr Patrizia Künzler-Heule (Moderator) Prof. Philip Larkin (Faculty) Dr Philip Berry (Faculty) All EASL St...

People suffering from alcohol-related liver (ALD) disorders are subject to several forms of stigma. If not addressed, stigma may lead towards unfavourable health outcomes. This JHEP Live – based on a recent review – discusses: What forms of stigma do people suffering from ALD face? How does stigma affect them? What can be done about it? ℹ️ Read this article for more information: G. Schomerus et al...

This episode of EASL Studio discusses the latest data in the treatment of NAFLD presented at the EASL NAFLD Summit 2022. Faculty Prof. Amalia Gastaldelli (Faculty) Prof. Frank Tacke (Faculty) Prof. Emmanuel Tsochatzis (Faculty) All EASL Studio Podcasts are available on EASL Campus .

This EASL Studio discusses important issues related to the opportunities and challenges of liver transplantation in acute-on-chronic liver failure (ACLF). Does urgent liver transplantation improve the survival of patients with ACLF-3 and where are the limits? Are the current allocation systems adequate and how to implement ACLF criteria for prioritisation? The distinct lack of equity of access of...

 Several recent reports have postulated a link between autoimmune hepatitis (AIH) following SARS-CoV-2 infection or vaccination. This EASL Studio JHEP Live discuss the potential links between COVID-19 and AIH. Faculty Prof. Vlad Ratziu (Moderator) Prof. Naga Chalasani (Moderator) Prof. Fernando Bril (Faculty) Prof. Robert Fontana (Faculty) Dr Johannes Hartl (Faculty) ℹ️ More information on the top...

This is the audio version of an episode that was originally broadcast live from The International Liver Congress 2022. Discover all the EASL Studio episodes at ILC 2022 here .

This is the audio version of an episode that was originally broadcast live from The International Liver Congress 2022. Discover all the EASL Studio episodes at ILC 2022 here .

This is the audio version of an episode that was originally broadcast live from The International Liver Congress 2022. Discover all the EASL Studio episodes at ILC 2022 here .

This is the audio version of an episode that was originally broadcast live from The International Liver Congress 2022. Discover all the EASL Studio episodes at ILC 2022 here .

This is the audio version of an episode that was originally broadcast live from The International Liver Congress 2022. Discover all the EASL Studio episodes at ILC 2022 here .

Issues of climate change, global warming and sustainability are taking centre stage in political agendas across the globe, causing major restructuring in many sectors. But, what about the healthcare sector? How is climate change affecting healthcare? How big of a problem is climate change for liver care? What public health strategies can be implemented to mitigate the effects of climate change? Yo...

In honour of World Haemochromatosis week (1-7 June 2022) the newly updated EASL Clinical Practice Guidelines on Haemochromatosis will be discussed in this episode of EASL Studio. Read more All EASL Studio Podcasts are available on EASL Campus .

Mouse models, based on dietary, chemical or genetic interventions, are designed to serve as tools to understand human liver diseases. With the number of models increasing: What types of models exist for hepatocellular carcinoma? How close do they mirror human liver cancer (subtypes)? Can they be used to predict therapeutic response? What are the best models? For which questions? From idea to conce...

In the assessment of disease stage, liver pathology is still largely based on semi-quantitative methods. Recent advances in whole slide imaging have opened the door for the use of artificial intelligence (AI) and the creation of machine learning (ML) algorithms. What exactly is digital pathology? How can it be implemented in different disease areas? Can it be used in routine clinical practice? Rea...